| Nov 25 | Feb 26 | May 26 | Aug 26 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Buy | — | — | — | — | — | — | — | — | — | — | — | — |
| Sell | — | — | — | — | — | — | 4 | — | 4 | — | — | — |
| total | individual payouts | |
|---|---|---|
| 2025 | ‡‡‡ |
|
| 2024 | ‡‡‡ |
|
| 2023 | ‡‡‡ |
|
| 2022 | ‡‡‡ |
|
| 2021 | ‡‡‡ |
|
| 2020 | ‡‡‡ |
|
| 2018 | ‡‡‡ |
|
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Cash | 198.47 | 78.76 | 76.96 | 65.45 |
| Receivables | 219.13 | 258.27 | 287.79 | 285.47 |
| Inventory | — | — | — | — |
| Other | 14.05 | — | — | — |
| 417.60 | 337.04 | 364.75 | 350.92 |
| 2023 | 2024 | 2025 | Q'26 | |
|---|---|---|---|---|
| Payables | 109.81 | 146.81 | 125.30 | 141.43 |
| ST’ Debt | 18.53 | — | — | — |
| Other | 10.74 | 17.99 | 4.50 | 0.26 |
| 145.26 | 193.77 | 157.52 | 169.90 |
| 10y | 5y | 3y | |
| Sales | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Cash Flow | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Earnings | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Book Value | — | ‡‡‡‡‡ | ‡‡‡‡‡ |
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 240.18 | 244.85 | 240.58 | — |
—
|
| ’25 | 253.68 | 250.45 | 205.26 | 289.98 |
999.38
|
| ’24 | 238.52 | 228.01 | 221.11 | 245.27 |
932.91
|
| ’23 | 231.05 | 241.04 | 247.25 | 238.00 |
957.34
|
| ’22 | 203.34 | 212.58 | 227.06 | 228.56 |
871.55
|
| ’21 | 122.88 | 139.03 | 154.88 | 183.88 |
600.67
|
| ’20 | 101.55 | 110.70 | 118.15 | 112.08 |
442.48
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 16.51 | 37.23 | 0.21 | — |
—
|
| ’25 | 5.69 | 40.95 | 11.39 | 10.27 |
68.29
|
| ’24 | 21.00 | 43.13 | 5.15 | (0.78) |
68.50
|
| ’23 | 29.72 | 47.94 | 33.11 | 39.22 |
149.99
|
| ’22 | 27.45 | 46.53 | 24.78 | 61.92 |
160.69
|
| ’21 | 27.74 | 27.60 | 18.35 | 45.23 |
118.91
|
| ’20 | 19.00 | 15.15 | 14.97 | 1.62 |
50.74
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | 12.41 | 26.62 | (3.80) | — |
—
|
| ’25 | 4.26 | 40.41 | 10.53 | 7.44 |
62.65
|
| ’24 | 19.98 | 41.38 | 3.28 | (2.61) |
62.03
|
| ’23 | 25.69 | 43.08 | 27.85 | 37.13 |
133.75
|
| ’22 | 22.70 | 41.54 | 21.17 | 57.05 |
142.46
|
| ’21 | 26.99 | 25.39 | 16.34 | 42.23 |
110.95
|
| ’20 | 15.93 | 10.87 | 12.18 | (0.44) |
38.53
|
| Sep | Dec | Mar | Jun | Year | |
|---|---|---|---|---|---|
| ’26 | (0.20) | (0.17) | (10.17) | — |
—
|
| ’25 | 0.05 | 0.14 | 0.23 | 0.03 |
0.47
|
| ’24 | 0.27 | 0.17 | (0.04) | (0.04) |
0.37
|
| ’23 | 0.65 | 0.31 | 0.51 | 0.50 |
1.95
|
| ’22 | 0.49 | 0.37 | 0.47 | 0.59 |
1.91
|
| ’21 | 0.15 | 0.18 | 0.32 | 0.39 |
1.02
|
| ’20 | 0.32 | (0.32) | 0.33 | 0.14 |
0.47
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 61.55 | 44.62 | 23.28 | 6.02 | — | — | — |
Low Price
|
| — | — | ‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 167.98 | 95.00 | 81.06 | 34.94 | — | — | — |
High Price
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 11,853 | 12,063 | 12,085 | 11,479 | — | — | — |
Employees
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 0.07 | 0.08 | 0.08 | 0.09 | — | — | — |
Revenue/Emp
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 871.55 | 957.34 | 932.91 | 999.38 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.28% | 33.23% | 24.26% | 25.08% | — | — | — |
Gross Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 136.28 | 137.52 | 33.98 | 31.20 | — | — | — |
EBT
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.64% | 14.36% | 3.64% | 3.12% | ‡‡‡ | ‡‡‡ | ‡‡‡ |
EBT Margin
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 110.61 | 113.43 | 21.56 | 27.45 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Net Income
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 38.56 | 39.66 | 49.04 | 58.16 | — | — | — |
Depreciation
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.49 | 16.70 | 16.00 | 17.09 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Revenue/Sh
|
| ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ | 1.97 | 1.98 | 0.37 | 0.47 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Earnings/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.86 | 2.62 | 1.17 | 1.17 | — | — | — |
Cash Flow/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (0.32) | (0.28) | (0.11) | (0.10) | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Capex/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 2.53 | 2.33 | 1.06 | 1.07 | — | — | — |
Free CF/Sh
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 10.24 | 12.01 | 13.81 | 12.90 | — | — | — |
Book Value/Sh
|
| — | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 56.27 | 57.32 | 58.32 | 58.46 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ |
Shares
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 44.81 | 26.16 | 80.83 | 32.60 | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡ |
PE Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.70 | 3.10 | 1.82 | 0.90 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PS Ratio
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 8.62 | 4.31 | 2.11 | 1.19 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
PB Ratio
|
| ‡‡‡ | ‡‡‡ | ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 5.53 | 2.99 | 1.95 | 1.07 | ‡‡‡‡ | ‡‡‡ | ‡‡‡‡ |
EV/Sales
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 33.82 | 21.37 | 29.32 | 17.09 | — | — | — |
EV/FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 160.69 | 149.99 | 68.50 | 68.29 | ‡‡‡ | ‡‡‡ | ‡‡‡ |
Op' Cash Flow
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (18.23) | (16.25) | (6.47) | (5.65) | ‡‡‡‡‡ | ‡‡‡‡‡ | — |
Capex
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 142.46 | 133.75 | 62.03 | 62.65 | — | — | — |
FCF
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 265.91 | 272.33 | 143.27 | 207.23 | — | — | — |
Working Cap'
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 67.88 | 87.74 | 182.30 | 234.16 | — | — | — |
Total Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | (149.35) | (110.73) | 103.54 | 157.20 | — | — | — |
Net Debt
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 576.00 | 688.20 | 805.33 | 754.38 | — | — | — |
Sh' Equity
|
| ‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 15.10% | 12.92% | 1.96% | 2.21% | — | — | — |
ROA
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 18.74% | 14.83% | 1.74% | 2.80% | — | — | — |
ROIC
|
| ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | ‡‡‡‡‡ | 22.56% | 17.94% | 2.89% | 3.52% | — | — | — |
ROE
|
Endava PLC (DAVA), once a high-flying IT services star with explosive growth during the pandemic, has tumbled to bargain-basement levels, trading at a fraction of its 2021 $170 peaks amid cyclical headwinds in tech spending. Revenue soared at a 25% CAGR to nearly $1 billion by 2023, fueled by acquisitions, a nearshore talent model in Eastern Europe, and efficiency gains like revenue per employee jumping 84% to $79,000. Profitability peaked with 15%+ EBT margins and strong free cash flow, but 2024 brought reality: a 2.5% revenue slip, gross margins cratering to 24%, and net income halving as clients in finance and payments pulled back post-rate hikes.
Despite the bruises—ROIC down to 1.7%, rising debt, and no insider buys signaling caution—fundamentals whisper resilience, with positive FCF covering obligations and employee headcount stabilizing around 11,500. Analysts see 34% average upside to their targets (up to 144%), betting on a rebound via AI partnerships and modernization demand, projecting revenue growth resuming at 7% in 2025 toward a $1.09 billion run-rate by 2028.
At 0.9x sales and forward PEs dropping to 11x by 2028, DAVA looks like a beaten-down value play for patient investors eyeing IT revival. But can margins snap back and leadership spark a comeback, or will macro risks linger? Dive into the full analysis for the charts, projections, and buy-or-bail verdict.
Keep track of companies that you follow and research.
Full access to our data with predictions and indicators that we calculate daily.
Full access to our screener with tons of custom values and customizable email notifications.
Excel export of financials and screeners you define and save.